February 2022

Steve Elster appeals a decision of the Trademark Board affirming an examiner’s refusal to register the trademark “TRUMP TOO SMALL” for use on T-shirts based on section 2(c) of the…

In 2015, Alarm filed petitions seeking inter partes reviews (IPRs) of claims of three patents owned by Vivint, Inc. The IPRs were instituted, and in 2017 the Board issued three…

Intuitive appeals from a final written decision of the Board upholding the patentability of claims 24–26 of U.S. Patent No. 8,479,969 relating to a robotically controlled endoscopic surgical instrument. The CAFC…

Adapt appeals the District Court’s final judgment of invalidity with respect to several patents related to methods of treating opioid overdose by intranasal administration of a naloxone (NARCAN®).  In 2012,…

Velodyne and Quanergy both market products employing laser systems. Quanergy filed two inter partes review (“IPR”) proceedings challenging the validity of multiple claims in U.S. Patent No. 7,969,558 directed to…

Myco began marketing a product for treating blepharitis called the AB Max at a trade show. A month later, BlephEx filed an application that would become United States Patent No.…

Qualcomm appeals from two related IPR decisions of the Board finding several claims of Qualcomm’s U.S. Patent No. 8,063,674 unpatentable under 35 U.S.C. § 103. To reach its unpatentability finding,…